RESULTS.
By the time the frequency of point mutations had climbed to ~1/10,000 bases, all mice had dilated, fibrotic hearts. Increased apoptosis preceded signs of disease by about 1 week. Consistent with a mitochondrial role in cell death, cyt c was released from mitochondria, beginning at the same time as the onset of increased apoptosis. Given the potential role of the permeability transition pore in cell death and cyt c release (4), we assessed pore function in isolated heart mitochondria.
Mitochondria from mice with mtDNA mutations exhibited perturbed pore opening caused by low calcium, and even with maximal pore induction (100 µM Ca ++ ) retained their cyt c, unlike mitochondria from mice without mutations ( Fig. 1; other figures appear at end of paper). The disturbed pore function and cyt c release suggest a striking change in the mitochondrial permeability properties, possibly mediated by cyclophilin D. The dual roles of cyclophilin D as a peptidyl-prolyl isomerase and a pore regulator (4) uniquely enable this protein to act as a detector of malfolded mitochondrial proteins; indeed, cardiomyopathy was prevented by treatment with the cyclophilin inhibitor cyclosporin A. SUMMARY. Apoptotic signaling, including opening of the mitochondrial permeability transition pore, is altered in mice with mtDNA mutations. Further, the disease that follows can be prevented by CsA, an inhibitor of pore opening and apoptosis. We hypothesize that cyclophilin D acts as a detector of mutations and signals the cell through altered pore function. Initiation of apoptosis is a dominant mechanism whereby rare mutations can result in disease.
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